Diffuse alveolar haemorrhage

Martina Bonifazi, Stefan Stanel, George A. Margaritopoulos

Source: Eur Respir Monogr 2019; 86: 173-187
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Martina Bonifazi, Stefan Stanel, George A. Margaritopoulos. Diffuse alveolar haemorrhage. Eur Respir Monogr 2019; 86: 173-187

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diffuse alveolar hemorrhage: how relevant is etiology?
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017


Pulmonary vasculitis presenting as acute diffuse alveolar haemorrhage (DAH)
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018


Diffuse alveolar hemorrhage and pulmonary fibrosis in MPO-ANCA-associated vasculitides
Source: Eur Respir J 2005; 26: Suppl. 49, 267s
Year: 2005

Diffuse alveolar hemorrhage - review of an interstitial lung disease clinic
Source: International Congress 2017 – Rare diseases
Year: 2017


Resolution of alveolar edema
Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling
Year: 2008

Diffuse alveolar hemorrhage caused by primary antiphospholipid syndrome
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012


Diffuse alveolar haemorrhage and pneumomediastinum after hypoglycaemic seizure
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013

Effectiveness of corticosteroid in diffuse alveolar hemorrhage with hematologic malignancy
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019

Idiopathic alveolar lipoproteinosis
Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases
Year: 2008



Simultaneous existence of diffuse alveolar damage and subpleural limited usual interstitial pneumonia lesion ( focal-UIP ) in clinical acute interstitial pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 43s
Year: 2003

Alveolar hemorrhage syndrome in children
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018




Broncholithiasis as a cause of pulmonary hemorrhages
Source: Eur Respir J 2007; 30: Suppl. 51, 543s
Year: 2007

Diffuse Alveolar Hemorrhage: a life-threatening adverse effect of vaping
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020


Diffuse dendriform pulmonary ossification in a usual interstitial pneumonia-like distribution: A distinct entity or a variant of idiopathic pulmonary fibrosis?
Source: International Congress 2014 – ILDs 1
Year: 2014


Diffuse parenchymal lung disease
Source: International Congress 2016 – Clinical year in review
Year: 2016


Diffuse parenchymal lung disease
Source: Eur Respir Rev, 26 (144) 170004; 10.1183/16000617.0004-2017
Year: 2017



Unilateral lung edema after the removal of spontaneous pneumothorax
Source: International Congress 2017 – Sepsis, infections, ARDS and beyond
Year: 2017


Idiopathic pulmonary haemosiderosis revisited
Source: Eur Respir J 2004; 24: 162-169
Year: 2004



Diffuse parenchymal lung diseases
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

Diffuse parenchymal lung diseases
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017